These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22398967)

  • 1. Warfarin-amiodarone drug-drug interactions: determination of [I](u)/K(I,u) for amiodarone and its plasma metabolites.
    McDonald MG; Au NT; Wittkowsky AK; Rettie AE
    Clin Pharmacol Ther; 2012 Apr; 91(4):709-17. PubMed ID: 22398967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of the interaction between amiodarone and warfarin in humans.
    Heimark LD; Wienkers L; Kunze K; Gibaldi M; Eddy AC; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1992 Apr; 51(4):398-407. PubMed ID: 1563209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms.
    McDonald MG; Au NT; Rettie AE
    Drug Metab Dispos; 2015 Nov; 43(11):1661-9. PubMed ID: 26296708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients.
    Ha HR; Bigler L; Wendt B; Maggiorini M; Follath F
    Eur J Pharm Sci; 2005 Mar; 24(4):271-9. PubMed ID: 15734293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of amiodarone metabolites in rats using UPLC-ESI-QTOFMS-based untargeted metabolomics approach.
    Jeong ES; Kim G; Yim D; Moon KS; Lee SJ; Shin JG; Kim DH
    J Toxicol Environ Health A; 2018; 81(12):481-492. PubMed ID: 29641932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone.
    Chen Y; Mao J; Hop CE
    Drug Metab Dispos; 2015 Feb; 43(2):182-9. PubMed ID: 25324279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay.
    Kuhn J; Götting C; Kleesiek K
    J Pharm Biomed Anal; 2010 Jan; 51(1):210-6. PubMed ID: 19720490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.
    Herman D; Locatelli I; Grabnar I; Peternel P; Stegnar M; Lainscak M; Mrhar A; Breskvar K; Dolzan V
    Eur J Clin Pharmacol; 2006 Apr; 62(4):291-6. PubMed ID: 16552506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of amiodarone and desethylamiodarone in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry with an ion trap detector.
    Kollroser M; Schober C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):219-26. PubMed ID: 11824809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone reduces plasma warfarin clearance in man.
    Watt AH; Stephens MR; Buss DC; Routledge PA
    Br J Clin Pharmacol; 1985 Dec; 20(6):707-9. PubMed ID: 4092002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high-resolution mass spectrometry and multiple-stage mass spectrometry: characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicity.
    Ramesh Varkhede N; Jhajra S; Suresh Ahire D; Singh S
    Rapid Commun Mass Spectrom; 2014 Feb; 28(4):311-31. PubMed ID: 24395499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.
    Almog S; Shafran N; Halkin H; Weiss P; Farfel Z; Martinowitz U; Bank H
    Eur J Clin Pharmacol; 1985; 28(3):257-61. PubMed ID: 4007030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enantioselective determinination of R-warfarin/S-warfarin in human plasma using liquid chromatography-tandem mass spectrometry and its application in a drug-drug interaction study].
    Jin S; Zhang YF; Chen XY; Liu K; Zhong DF
    Yao Xue Xue Bao; 2012 Jan; 47(1):105-9. PubMed ID: 22493814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro amiodarone protein binding and its interaction with warfarin.
    Neyroz P; Bonati M
    Experientia; 1985 Mar; 41(3):361-3. PubMed ID: 3972082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
    Miano TA; Yang W; Shashaty MGS; Zuppa A; Brown JR; Hennessy S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1446-1456. PubMed ID: 32112562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Deng P; You T; Chen X; Yuan T; Huang H; Zhong D
    Drug Metab Dispos; 2011 Jun; 39(6):1058-69. PubMed ID: 21398391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry.
    Maes A; Baert K; Croubels S; De Clercq D; van Loon G; Deprez P; De Backer P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):47-56. PubMed ID: 16616880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.
    Sanoski CA; Bauman JL
    Chest; 2002 Jan; 121(1):19-23. PubMed ID: 11796427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.
    Jones DR; Boysen G; Miller GP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1056-62. PubMed ID: 21470921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.